Applied Genetic Technologies reported $19.71M in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Alimera Sciences ALIM:US $ 10.31M 0.9M
Applied Genetic Technologies AGTC:US $ 19.71M 3.16M
Avrobio Inc AVRO:US $ 16.95M 4.18M
Biogen BIIB:US $ 3347.2M 181.4M
Bluebird Bio BLUE:US $ 247.76M 41.45M
Celldex Therapeutics CLDX:US $ 14.49M 2.49M
Cti Biopharma CTIC:US $ 15.79M 0.23M
Gilead Sciences GILD:US $ 10214M 509M
Insmed INSM:US $ 99.66M 18.26M
Intercept Pharmaceuticals ICPT:US $ 145.28M 0.95M
Life Technologies LIFE:US $ 7.28M 2.83M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Rigel Pharmaceuticals RIGL:US $ 59.54M 7.52M
Ultragenyx Pharmaceutical RARE:US $ 127.07M 0.02M